The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
ESR-alpha promoter methylation to predict survival in low-grade ovarian cancer.
Verena Engelstaedter
No relevant relationships to disclose
Rong Shi
No relevant relationships to disclose
Sabine Heublein
No relevant relationships to disclose
Christina Kuhn
No relevant relationships to disclose
Klaus Friese
No relevant relationships to disclose
Doris Mayr
No relevant relationships to disclose
Udo Jeschke
No relevant relationships to disclose